1858 Wealth Management LLC Purchases 435 Shares of Zoetis Inc. (NYSE:ZTS)

1858 Wealth Management LLC boosted its position in Zoetis Inc. (NYSE:ZTS) by 24.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,223 shares of the company’s stock after acquiring an additional 435 shares during the period. 1858 Wealth Management LLC’s holdings in Zoetis were worth $362,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. Darwin Wealth Management LLC purchased a new stake in shares of Zoetis during the third quarter worth about $31,000. First Personal Financial Services bought a new position in Zoetis during the 3rd quarter valued at approximately $33,000. Capital Performance Advisors LLP purchased a new stake in Zoetis in the 3rd quarter worth approximately $33,000. Dunhill Financial LLC grew its position in shares of Zoetis by 80.6% in the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock worth $33,000 after buying an additional 75 shares during the last quarter. Finally, Fortitude Family Office LLC increased its stake in shares of Zoetis by 1,387.5% during the third quarter. Fortitude Family Office LLC now owns 238 shares of the company’s stock valued at $46,000 after buying an additional 222 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Leerink Partners began coverage on Zoetis in a research note on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price target for the company. UBS Group began coverage on shares of Zoetis in a research report on Monday, December 9th. They issued a “neutral” rating and a $196.00 target price for the company. Morgan Stanley cut their target price on shares of Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 29th. Stifel Nicolaus decreased their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Finally, Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $215.00.

Zoetis Price Performance

Shares of NYSE ZTS opened at $172.24 on Wednesday. The company has a 50 day simple moving average of $169.48 and a two-hundred day simple moving average of $179.39. Zoetis Inc. has a fifty-two week low of $144.80 and a fifty-two week high of $200.53. The company has a market capitalization of $77.71 billion, a price-to-earnings ratio of 32.38, a P/E/G ratio of 2.72 and a beta of 0.90. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The company had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. During the same quarter last year, the company earned $1.36 EPS. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. Analysts expect that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This is an increase from Zoetis’s previous quarterly dividend of $0.43. This represents a $2.00 annualized dividend and a dividend yield of 1.16%. Zoetis’s dividend payout ratio (DPR) is presently 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.